Halima Medjahed

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Journal: mBio

Published: July 29, 2026

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

HIV-1 soluble gp120 in cerebrospinal fluid is associated with poorer motor domain neurocognitive performance in virally suppressed people with HIV.

HIV-1 soluble gp120 in cerebrospinal fluid is associated with poorer motor domain neurocognitive performance in virally suppressed people with HIV.

Journal: AIDS (London, England)

Published: December 17, 2025

Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicity.

Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicity.

Journal: Journal of virology

Published: December 09, 2025

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.

Journal: mBio

Published: September 08, 2025

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques.

Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques.

Journal: Journal of virology

Published: April 07, 2025

Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2.

Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2.

Journal: Viruses

Published: April 04, 2025

A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120.

A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120.

Journal: Journal of virology

Published: March 27, 2025

CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWH.

CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWH.

Journal: EBioMedicine

Published: March 17, 2025

CD4 T cell counts are inversely correlated with anti-cluster A antibodies in antiretroviral therapy-treated PLWH.

CD4 T cell counts are inversely correlated with anti-cluster A antibodies in antiretroviral therapy-treated PLWH.

Journal: medRxiv : the preprint server for health sciences

Published: March 10, 2025

Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.

Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.

Journal: Virology

Published: October 30, 2024

Showing 1-12 of 89

Last Updated: 09/26/2026